Publication | Closed Access

Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues

Prostaglandin I2 AnaloguesMedicineFunctional SelectivityG Protein-coupled ReceptorImmunologyReceptor (Biochemistry)Pulmonary PharmacologyBronchial NeoplasmPharmacologyCell SignalingLung CancerMolecular ConjugatesDrug Discovery